Showing results (81-90 of 375) with videos related to
Sort By:
Pageof 38
Frontiers in Oncology|April 17, 2020
PI(3,4)P2 Signaling in Cancer and MetabolismLuca Gozzelino, Maria Chiara De Santis, Federico Gulluni, et al.Molecules (Basel, Switzerland)|April 3, 2021
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerClaudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, et al.Oncoimmunology|July 29, 2016
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell responsePaola Cappello, Elisabetta Tonoli, Roberta Curto, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The dark side of immunotherapy: pancreatic cancerGianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, et al.Cancers|February 22, 2018
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersPaola Cappello, Claudia Curcio, Giorgia Mandili, et al.Antioxidants (Basel, Switzerland)|April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with GemcitabineCecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.European Journal of Medicinal Chemistry|January 25, 2021
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectivesValentina Sala, Sophie Julie Cnudde, Alessandra Murabito, et al.Cancers|March 30, 2017
PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney CystsMaria Chiara De Santis, Valentina Sala, Miriam Martini, et al.Current Heart Failure Reports|April 29, 2017
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF)Valentina Sala, Jean Piero Margaria, Alessandra Murabito, et al.Science Signaling|June 11, 2009
PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3,4,5)P3 pools in mast cellsThomas Bohnacker, Romina Marone, Emilie Collmann, et al.Pageof 38